← Eichor
Study identifier: NCT06241274 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Moxibustion in the Treatment of Hemorrhagic Cystitis After Allo-HSCT

Condition: Moxibustion · Hematopoietic Stem Cell Transplantation · Hemorrhagic Cystitis  ·  Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

PhaseNA
Planned participants60
Who can joinAll sexes, 18 Years to 55 Years
Healthy volunteersNo

About this study

This study was a prospective, multicenter, single-arm clinical study planned to enroll 60 patients who developed hemorrhagic cystitis after sexually allogeneic hematopoietic stem cell transplantation Patients with hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation were given symptomatic supportive treatment combined with moxibustion covering Shenque, Zhongguo, Guanyuan, and Qihai for 30 minutes every day for 14 days and urine routine was collected every day for 14 days to assess the severity of hemorrhagic cystitis and pain scores to evaluate the effectiveness of moxibustion in treating hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation.

This description comes directly from the study's public registry record.

Talk to the study team

Yi Zhang  ·  +86 15639790587  ·  zy188603@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Yi ZhangWuhan, Hubei, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06241274